pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
XLNT-1
Metastatic Ovarian Cancer
Nami Therapeutics Corp
0
catalysts
Preclinical
XLRS Gene Therapy Program
Retinal Degeneration
TeamedOn International Inc
0
catalysts
Preclinical
XM-14601
Pancreatic Ductal Adenocarcinoma
Excellamol Inc
0
catalysts
Preclinical
XM-161SN38
High-Grade Glioma
← prev
page 149 of 231
next →
131
Pain
89
Neurology
1
Excellamol Inc
0
catalysts
Phase 3
XRx-026
oxypurinol
Gouty Arthritis (Gout)
Xanthine dehydrogenase/oxidase
$XRTX
XORTX Therapeutics Inc.
0
catalysts
Phase 3
XT-150
Osteoarthritis Pain
Xalud Therapeutics Inc
0
catalysts
Preclinical
XTX-501
Non-Small Cell Lung Cancer
$XLO
Xilio Therapeutics, Inc.
0
catalysts
Phase 1
XW-014
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Hangzhou Sciwind Biosciences Co Ltd
0
catalysts
Preclinical
XYA-01
Triple-Negative Breast Cancer (TNBC)
Xyone Therapeutics Inc
0
catalysts
Preclinical
XYA-02
Pancreatic Ductal Adenocarcinoma
Xyone Therapeutics Inc
0
catalysts
Marketed
Xembify
Xembify (immune globulin (human)-klhw)
Primary Immune Deficiency (PID)
Grifols Biologicals Inc (Inactive)
0
catalysts
Phase 2
XmAb bispecific antibody
Unspecified Cancer
$NVS
NOVARTIS AG
0
catalysts
Marketed
Xphozah
Xphozah (tenapanor hydrochloride)
Hyperphosphatemia In Chronic Kidney Disease
$ARDX
ARDELYX, INC.
0
catalysts
Phase 2
YA-101
Multiple System Atrophy (Multi-System Degeneration)
Yoda Pharmaceuticals Inc
0
catalysts
Preclinical
YB-200
Hepatocellular Carcinoma
Ymmunobio AG
0
catalysts
Phase 1
YENEO-001
Colorectal Cancer
NantBio Inc
0
catalysts
Phase 2
YG-1699
Type 1 Diabetes (Juvenile Diabetes)
Youngene Therapeutics Co Ltd
0
catalysts
Phase 1
YH-013
Solid Tumor
Eucure (Beijing) Biopharma Co Ltd
0
catalysts
Phase 2
YH-12852
Diabetic Gastroparesis
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 2
YH-42946
Non-Small Cell Lung Cancer
Yuhan Corp
0
catalysts
Phase 2
YL-13027
Solid Tumor
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 2
YL-15293
Colorectal Cancer
Shanghai Yingli Pharmaceutical Co Ltd
0
catalysts
Phase 1
YL-217
Colorectal Cancer
Suzhou Medilink Therapeutics Ltd
0
catalysts
Preclinical
YN-014
Alzheimer's Disease
Shanghai Innogen Pharmaceutical Technology Co Ltd
0
catalysts
Phase 2
YPP-10
Keratoconjunctivitis Sicca (Dry Eye)
Yuyu Pharma Inc
0
catalysts
Phase 2
YR-001
Atopic Dermatitis (Atopic Eczema)
YIRUI Pharmaceutical Technology Co Ltd
0
catalysts
Phase 1
YUQA-1007
Inflammatory Bowel Disease
AllianThera Biopharma
0
catalysts
Marketed
Yasmin
Yaz ((drospirenone + ethinylestradiol))
Acne Vulgaris
Bayer HealthCare Pharmaceuticals Inc
0
catalysts
Marketed
Yonsa
Yonsa (abiraterone acetate)
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sun Pharmaceutical Industries Ltd
0
catalysts
Phase 2
ZEN-3694
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Zenith Epigenetics Ltd
0
catalysts
